Embrex Announces First Quarter 2006 Financial Results Release and Conference Call

Embrex(R), Inc., The In Ovo Company(R), (Nasdaq:EMBX)
announced Embrex management intends to file its First Quarter 2006
Form 10-Q and issue its financial press release on Monday, May 8,
2006. Embrex's management, led by President and CEO Randall L.
Marcuson, will further discuss these financial results in a conference
call on Tuesday, May 9, at 11:00 a.m. ET. To join the conference call,
dial 800-446-9604 (domestic and Canada), or 706-643-5312
(international), identify Randall Marcuson (or Don Seaquist) as the
conference leader, and if asked, provide conference identification
number 8361365.
   This call is being webcast by Thomson/CCBN and can be accessed at
Embrex's website at www.embrex.com. Click on the Investor Info button
to access the link.
   The webcast is also being distributed over Thomson/CCBN's Investor
Distribution Network to both institutional and individual investors.
Individual investors can listen to the call through Thomson/CCBN's
individual investor center at www.earnings.com or by visiting any of
the investor sites in Thomson/CCBN's Individual Investor Network.
Institutional investors can access the call via Thomson/CCBN's
password-protected event management site, StreetEvents
(www.streetevents.com).
   A telephone replay will be available from approximately 2 p.m. ET
May 9 to midnight ET May 23 by dialing 800-642-1687 (domestic and
Canada), or 706-645-9291 (international), conference ID 8361365.
   Embrex(R), Inc., The In Ovo Company(R), is an international
agricultural biotechnology company engaged in the development of
innovative in ovo (in the egg) solutions that meet the needs of
today's global poultry industry.

   Embrex(R) and The In Ovo Company(R) are trademarks of Embrex, Inc.